R1 Therapeutics is debuting with an oversubscribed $77.5 million series A financing aimed at advancing its first-in-class ...
Pharmaceutical Technology on MSN
R1 Therapeutics raises $77.5M to progress AP306 for hyperphosphatemia
R1 plans to initiate a Phase IIb study of AP306 later this year.
Series A co-led by Abingworth, DaVita Venture Group, and F-Prime with participation from Curie.Bio, SymBiosis, and U.S. Renal CarePartnership ...
The startup believes a pill it licensed from a Chinese biotech company could be more potent, and convenient to take, than existing treatments for a common complication of chronic kidney disease.
R1 Therapeutics has launched with an oversubscribed $77.5 million Series A financing and an exclusive global licence to ...
Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. Once hyperphosphatemia occurs, we like to ...
– Patient-reported outcomes from Phase 2 trial of oxylanthanum carbonate (OLC) demonstrate high patient satisfaction with OLC compared to their prior phosphate lowering therapy – – Findings from a ...
Please provide your email address to receive an email when new articles are posted on . “So, what can we do beyond binders?” he asked during the presentation. One method is to increase the frequency ...
LOS ALTOS, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics (UNCY), Inc. , a clinical-stage biotechnology company developing therapies for patients with kidney disease, today ...
WALTHAM, Mass., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class ...
The FINANCIAL — Astellas Pharma Inc. announced that it launched Kiklin Granules 86.2% (generic name: bixalomer, “Kiklin Granules”), an additional formulation of Kiklin Capsules 250 mg (“Kiklin ...
As a physician and researcher caring for people with chronic kidney disease, I see firsthand the challenges that patients undergoing dialysis face. Dialysis is life-sustaining, but it also brings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results